48 result(s) for 'Automated IHC Workflow'
21 - 30 of 48 results for 'Automated IHC Workflow'
Sort by
Show
The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments.
NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers with a high-performing IHC Mismatch Repair (MMR) option when screening colorectal cancer patients for the identification of probable Lynch syndrome.
“Pathologists can utilize the Leica Biosystems BOND MMR panel on the BOND-III for clear, accurate assessment of mismatch repair protein status in only 2.5 hours,” said Dr. Robert Monroe, Chief Medical Officer at Leica Biosystems. “With this panel, clinicians can feel increased confidence in their MMR results.” Colorectal cancer (CRC) is the...
It’s Time for TIME Alexander “Sandy” Borowsky Professor of Pathology and Laboratory Medicine Center for Immunology and Infectious Diseases
Disclosures Bristol-Meyers Squibb/Celgene: Funded through Investigator Sponsored Research (ISR) program. Discovery proposal. Leica/Aperio: Funded to run the “Genesis” study for primary diagnosis from whole slide images. Honorarium for this presentation. Histolix: Slide-free histology (Levenson and Fereidouni). Pfizer: Pfizer Protocol A9001502, Treatment Resistance Following Therapies (TRANSLATE) site PI. Agenda: In contracting to join the “FLEX” registry. None of these has actually paid me, only funding for the research projects.
Objectives • Introduction into the complexity of the TIME and the development of new cancer treatments though di...